Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20972880 | 0.96 | KMT2A (0.44) | KMT2AATMELANEMEN1TNK2 | |
| SCHEMBL17754325 | 0.91 | KMT2A (0.37) | KMT2AATMELANEMEN1TNK2 | |
| SCHEMBL17754341 | 0.89 | APP (0.42) | KMT2AATMELANEMEN1TNK2 | |
| SCHEMBL22459337 | 0.88 | KMT2A (0.36) | KMT2AATMELANEMEN1LMNA | |
| SCHEMBL22109919 | 0.87 | EPHX1 (0.38) | KMT2AATMELANEMEN1TNK2 | |
| SCHEMBL17754315 | 0.86 | APP (0.43) | KMT2AATMMEN1TNK2HSD11B1 | |
| SCHEMBL17750863 | 0.85 | APP (0.37) | KMT2AATMELANEMEN1TNK2 | |
| SCHEMBL8639291 | 0.83 | POLB (0.53) | KMT2AMEN1TNK2 | |
| SCHEMBL21003911 | 0.82 | MEN1 (0.40) | KMT2AMEN1TNK2HSD11B1PTPN1 | |
| SCHEMBL3278746 | 0.81 | MEN1 (0.40) | KMT2AMEN1LMNASMN1; SMN2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| US-8089584-B2 | Liquid crystal display panel and method for fabricating the same | AU OPTRONICS CORP. (TW) | 2012-01-03 | — | — | US | disclosed |
| US-8089584-B2 | Liquid crystal display panel and method for fabricating the same | AU OPTRONICS CORP. (TW) | 2012-01-03 | — | — | US | disclosed |
| US-8089584-B2 | Liquid crystal display panel and method for fabricating the same | AU OPTRONICS CORP. (TW) | 2012-01-03 | — | — | US | disclosed |
| US-20100238382-A1 | LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR FABRICATING THE SAME | AU OPTRONICS CORP. (TW) | 2010-09-23 | — | — | US | disclosed |
| US-20100238382-A1 | LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR FABRICATING THE SAME | AU OPTRONICS CORP. (TW) | 2010-09-23 | — | — | US | disclosed |
| US-20100238382-A1 | LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR FABRICATING THE SAME | AU OPTRONICS CORP. (TW) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | RCC1, LPXN, SMC4 | KMT2A 2308/4885ATM 3717/4885ELANE 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.